title: [Interest of bone alkaline phosphatase in hemodialysis patients].
abstract: BACKGROUND
  The renal osteodystrophy represent a major complication in hemodialysis.
  
  
  OBJECTIVE
  To evaluate the value of plasma bone-alkaline phosphatase (bAP) in the diagnosis of the type of renal osteodystrophy among hemodialysis patients and to seek a possible correlation between the bAP, total alkaline phosphatases (tAP) and the intact parathormone (iPTH).
  
  
  METHODS
  We studied 67 chronic hemodialysis patients. Plasma bAP was determined by immunoenzymatic technic. iPTH (1-84) was measured by electrochimiluminescence.
  
  
  RESULTS
  We found that bAP levels were normal (10-20 ng/ml) in 17 patients, low (< 10 ng/ml) in 4 and high (> 20 ng/ml) in the 46 other patients. There is a good positive correlation between the plasmatic rate of bAP and the following parameters: the period of dialysis (R = 0.316, p = 0.009), plasmatic rate of tAP (r = 0.781, p < 10(-3)) and the rate of iPTH (r = 0.650, p < 10(-3)). There is a good positive correlation between the plasmatic rate of bAP and the rates of the tAP and of iPTH, the correlation between bAP and the iPTH being more significant. A rate of bAP higher than 20 ng/ml had a sensitivity of 93.5%, specificity of 63.3% in favour of a rate of iPTH >400 pg/ml and consequently of the biological diagnosis of hyperparathyroidism. In addition, 4 patients have a bAP <10 ng/ml with iPTH < 150 pg/ml evoking an adynamic osteopathy.
  
  
  CONCLUSIONS
  plasma bAP provides useful information about bone remodelling in hemodialysis patients.
authors.affiliation: Service de Néphrologie et de Médecine interne, Hôpital Charles Nicolle, Bd. du 9 avril, Tunis, Tunisie.
authors.forename: Imed
authors.initials: I
authors.lastname: Helal
authors.forename: Afef
authors.initials: A
authors.lastname: Bahlous
authors.forename: Fethi
authors.initials: F
authors.lastname: El Younsi
authors.forename: Fethi
authors.initials: F
authors.lastname: Ben Hamida
authors.forename: Jaouida
authors.initials: J
authors.lastname: Abdelmoula
authors.forename: Chelbi
authors.initials: C
authors.lastname: Belkahia
authors.forename: Adel
authors.initials: A
authors.lastname: Kheder
mesh_terms: D000469:Alkaline Phosphatase / Q000097:blood*; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000097:blood* / Q000175:diagnosis* / Q000209:etiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects
chemical_list: D000469:Alkaline Phosphatase